A Pilot Study of <sup>18</sup> F‐rhPSMA‐7.3‐PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease
<sup>18</sup>F-rhPSMA-7.3-PET/MRI can detect occult higher risk disease in men who are otherwise candidates for AS or FT. The scan prompted major changes in management and increased confidence in the final treatment strategy.
Authors
- Derek G. Hesse (ORCID: https://orcid.org/0000-0002-9945-6408)
- Nikki Hubbard
- Hatice Savas (ORCID: https://orcid.org/0000-0002-9835-9630)
- Clayton Neill (ORCID: https://orcid.org/0009-0003-3603-9580)
- Hiten D. Patel
- Ashley E. Ross
- Yutai Li
- Sai Kumar
- Ridwan Alam
- Emma McGarrity
- Edward M. Schaeffer
- Nicole Handa
Institutions
- Northwestern University (US)
Publication Details
- Journal
- The Prostate
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1002/pros.70147
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00